Prostate Cancer Care: Advances in Risk Stratification, Imaging and Treatment

The management of prostate cancer continues to move toward increasingly individualized care, with advances in imaging, biopsy techniques, molecular imaging and minimally invasive treatment helping physicians more precisely identify clinically significant disease and tailor therapy to the individual patient.

By
September 29, 2026
5 min

Baptist Health South Florida

1

Advances in imaging and biopsy techniques enable more precise identification of clinically significant prostate cancer.
2

PSA testing remains crucial for early diagnosis, but results must be interpreted considering age, prostate size, and clinical history.
3

Multiparametric MRI enhances diagnosis and guides targeted biopsies, improving the accuracy of prostate cancer detection.
4

PSMA imaging significantly aids in localizing prostate cancer and assessing recurrence after treatment.
5

Artificial intelligence is emerging as a tool to enhance MRI interpretation and integrate various data for better risk stratification.

Prostate Cancer Care: Advances in Risk Stratification, Imaging and Treatment

1

2

3

4

5

Original Source(s)

Prostate Cancer Care: Advances in Risk Stratification, Imaging and Treatment

Related Content

Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI

Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study

Old disease, new twist